Durable partial response to carboplatin, paclitaxel, and pembrolizumab in squamous cell carcinoma of unknown primary: A case report

Medical Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles